Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Cited by (1,001)

Items 401–500 of 1,001

1. SWI/SNF Chromatin-Remodeling Factor Smarcd3/Baf60c Controls Epithelial-Mesenchymal Transition by Inducing Wnt5a Signaling
   Nicole Vincent Jordan, Aleix Prat, Amy N. Abell, Jon S. Zawistowski, Noah Sciaky, Olga A. Karginova, Bingying Zhou, Brian T. Golitz, Charles M. Perou, Gary L. Johnson · 2013 · Molecular and Cellular Biology
2. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture
   Agla J. Fridriksdottir, Jiyoung Kim, René Villadsen, Marie Christine Klitgaard, Branden Michael Hopkinson, OLE WILLIAM PETERSEN, Lone Rønnov‐Jessen · 2015 · Nature Communications
3. The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target
   Carla Boccaccio, Paolo Maria Comoglio · 2013 · Cancer Research
4. PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells
   Gilles Buchwalter, M. Hickey, A. Cromer, L. Selfors, R. Gunawardane, Jason Frishman, R. Jeselsohn, E. Lim, David Chi, Xiaosong Fu et al. · 2013 · Cancer Cell
5. Metabolic flexibility and cell hierarchy in metastatic cancer
   Michael V. Berridge, Patries M. Herst, An S. Tan · 2010 · Mitochondrion
6. Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis
   Shaheen S. Sikandar, Angera H. Kuo, Tomer Kalisky C, Shang Cai, Maider Zabala, Robert W. Hsieh, Neethan A. Lobo, Ferenc A. Scheeren, Sopheak Sim, Dalong Qian et al. · 2017 · Nature Communications
7. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
   Laksshman Sundaram, Arvind Kumar, Matthew Zatzman, Adriana Salcedo, Neal G. Ravindra, Shadi Shams, Brian H. Louie, S. Tansu Bagdatli, Matthew A. Myers, Shahab Sarmashghi et al. · 2024 · Science
8. Insights into the cell of origin in breast cancer and breast cancer stem cells
   Geoffrey John Lindeman, Jane E. Visvader · 2010 · Asia-Pacific Journal of Clinical Oncology
9. Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer
   Biao Geng, Manman Liang, Xiao-Bing Ye, Wenying Zhao · 2014 · Molecular and Clinical Oncology
10. Stem cells in prostate cancer: treating the root of the problem
    Renea A. Taylor, Roxanne Toivanen, Gail Petuna Risbridger · 2010 · Endocrine Related Cancer
11. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
    María Ángeles Castilla, María Ángeles López‐García, M. Atienza, Juan Manuel Rosa-Rosa, Juan Díaz‐Martín, María Luisa Pecero, Begoña Vieites, Laura Romero‐Pérez, Javier J. Benitez, Annarica Calcabrini et al. · 2014 · Endocrine Related Cancer
12. Dysregulation of histone methyltransferases in breast cancer – Opportunities for new targeted therapies?
    Ewa Malgorzata Michalak, Jane E. Visvader · 2016 · Molecular Oncology
13. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors
    Donnenberg, Vera S., Donnenberg, Albert D., Zimmerlin, Ludovic, Landreneau, Rodney J., Bhargava, Rohit, Wetzel, Ryan A., Basse, Per, Brufsky, Adam M. · 2010 · Cytometry Part B: Clinical Cytometry
14. Spindle cell lesions of the breast: a diagnostic approach
    Emad A. Rakha, Edi Brogi, Isabella Castellano, Cecily Quinn · 2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
15. Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis
    Kevin Nee, Dennis Ma, Quy Nguyen, Maren Pein, Nicholas Pervolarakis, Jacob Insua‐Rodríguez, Yanwen Gong, Grace A. Hernandez, Hamad S. Alshetaiwi, Justice Williams et al. · 2023 · Nature Genetics
16. Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers
    Marieke A. Vollebergh, Jos Jonkers, Sabine C. Linn · 2011 · Cellular and Molecular Life Sciences
17. Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
    Anjali Tikoo, Vincent Roh, Karen G. Montgomery, Ivan Ivetac, Paul Waring, Rebecca Pelzer, Lauren Hare, Mark J. Shackleton, Patrick Orson Humbert, Wayne Allen Phillips · 2012 · PLoS ONE
18. Leveraging premalignant biology for immune-based cancer prevention
    Avrum E. Spira, Mary Lenora Disis, John T. Schiller, Eduardo Vilar, Timothy Richard Rebbeck, Rafael L. Bejar, Trey Ideker, Janine Arts, Matthew B.B. Yurgelun, Jill P. Mesirov et al. · 2016 · Proceedings of the National Academy of Sciences
19. A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer
    Jeroen Verstappe, Geert Berx · 2023 · Seminars in Cancer Biology
20. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)
    Kristen M. Reipas, Jennifer H. Law, Nicole Couto, Sumaiya Islam, Yvonne Y. Li, Huifang Li, Artem R Cherkasov, Karen Jung, Amarpal S. Cheema, Steven J.M. Jones et al. · 2013 · Oncotarget
21. ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype
    Simon R. Junankar, Laura A. Baker, Daniel Lee Roden, Radhika Nair, Benjamin Elsworth, David Gallego‐Ortega, Paul A Lacaze, Aurélie Cazet, Iva Nikolić, Wee Siang Teo et al. · 2015 · Nature Communications
22. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer
    Simone Gastaldi, Francesco Paolo Sassi, Paolo Accornero, Davide Torti, Francesco Galimi, Giorgia Migliardi, Gemma Molyneux, Timothy Pietro Suren Perera, Paolo Maria Comoglio, Carla Boccaccio et al. · 2012 · Oncogene
23. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study
    Gretchen L. Gierach, Hui Li, Jennifer T. Loud, Mark H. Greene, Catherine K. Chow, Lan Li, Sheila Ann Prindiville, Jennifer Eng‐Wong, Peter W. Soballe, Claudia Giambartolomei et al. · 2014 · Breast Cancer Research
24. Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells
    Arthur W. Lambert, Chen Khuan Wong, Sait Ozturk, Panagiotis Papageorgis, Rekha Raghunathan, Yuriy O. Alekseyev, Adam C. Gower, Björn M. Reinhard, Hamid M. Abdolmaleky, Sam Thiagalingam · 2015 · Molecular Cancer Research
25. Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
    Carmela Ricciardelli, Noor A. Lokman, Carmen E. Pyragius, Miranda P. Ween, Anne M. Macpherson, Andrew R. Ruszkiewicz, Peter Hoffmann, Martin Klaus Oehler · 2017 · Oncotarget
26. RETRACTED ARTICLE: Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
    Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, Cecil Han, Yuanzhang Fang, Yujing Li, Kevin Van der Jeught, Hanchen Xu, Lu Zhang, Michael Frieden et al. · 2018 · Nature Communications · Retracted
27. Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer
    Arnaud Da Cruz Paula, Carlos Lopes · 2017 · Anticancer Research
28. A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers
    Rachael Natrajan, Alan G. Mackay, Maryou B. K. Lambros, Britta Weigelt, Paul M Wilkerson, Élodie Manié, Anita E. Grigoriadis, Roger A’Hern, Petra van der Groep, Iwanka Kozarewa et al. · 2012 · The Journal of Pathology
29. The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women
    Sung Jin Huh, Hannah Oh, Michael A. Peterson, Vanessa Almendro, Rong Hu, Michaela Bowden, Rosina L. Lis, Maura B. Cotter, Massimo F. Loda, William Thomas Barry et al. · 2016 · Cancer Research
30. Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention
    Justin A. Colacino, Sean McDermott, Maureen A. Sartor, Max S. Wicha, Laura S. Rozek · 2016 · Breast Cancer Research and Treatment
31. Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers
    Sewha Kim, Byung-In Moon, Woosung Lim, Sanghui Park, Min Sun Cho, Sun Hee Sung · 2018 · Clinical Breast Cancer
32. Assessing metastatic potential of breast cancer cells based on EGFR dynamics
    Yen‐Liang Liu, Chao‐Kai Chou, Mirae Kim, Rohan Vasisht, Yu-An Kuo, Phyllis Ang, Cong Liu, Evan P. Perillo, Yu‐An Chen, Katherine Blocher et al. · 2019 · Scientific Reports
33. Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer
    Mustafa M. Basree, Neelam Shinde, Christopher S. Koivisto, Maria C. Cuitiño, Raleigh D. Kladney, Jianying Zhang, Julie A. Stephens, Marilly S. Palettas, Allen Zhang, Hee Kyung Kim et al. · 2019 · Breast Cancer Research
34. Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis
    Stéphanie Cagnet, Marisa M. Faraldo, Maaike Kreft, Arnoud Sonnenberg, Karine Raymond, Marina A. Glukhova · 2013 · Oncogene
35. Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer
    Wen Bu, Jun Chen, G D Morrison, Shixia Huang, Chad J. Creighton, Jian Huang, Gary C. Chamness, Susan Galloway Hilsenbeck, Dennis R. Roop, Andrew D. Leavitt et al. · 2011 · Oncogene
36. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation
    F Bai, Matthew D. Smith, Ho Lam Chan, X-H Pei · 2012 · Oncogene
37. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer
    Meiyun Fan, Aarti Sethuraman, Martin Brown, WenLin Sun, Lawrence M. Pfeffer · 2014 · Breast Cancer Research and Treatment
38. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
    Lisa M. Arendt, Debra E. Rugowski, Tara L. Grafwallner-Huseth, Maria Jose Garcia-Barchino, Hallgeir Rui, Linda A. Schuler · 2011 · Breast Cancer Research
39. The mammary cellular hierarchy and breast cancer
    Samantha Richelle Oakes, David Gallego‐Ortega, Christopher John Ormandy · 2014 · Cellular and Molecular Life Sciences
40. Stem Cell Research: A Novel Boulevard towards Improved Bovine Mastitis Management
    Neelesh Sharma, Dong Kee Jeong · 2013 · International Journal of Biological Sciences
41. Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland
    Godde, Nathan J., Sheridan, Julie M., Smith, Lorey K., Pearson, Helen B., Britt, Kara L., Galea, Ryan C., Yates, Laura L., Visvader, Jane E., Humbert, Patrick O. · 2014 · PLoS Genetics
42. Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
    Patrick D. Rädler, Barbara L. Wehde, Aleata A. Triplett, Hridaya Shrestha, Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay‐Uwe Wagner · 2021 · Nature Communications
43. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models
    Lorenzo Melchor, Gemma Molyneux, Alan G. Mackay, Fiona‐Ann Magnay, M. Atienza, Howard D. Kendrick, Daniel Nava Rodrigues, María Ángeles López‐García, Fernanda Milanezi, Kirsty R. Greenow et al. · 2014 · The Journal of Pathology
44. Atbf1 Regulates Pubertal Mammary Gland Development Likely by Inhibiting the Pro-Proliferative Function of Estrogen-ER Signaling
    Mei Li, Xiaoying Fu, Gui Ma, Xiaodong Sun, Xue–Yuan Dong, Tamás Nagy, Changsheng Xing, Jie Li, Jin‐Tang Dong · 2012 · PLoS ONE
45. Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers
    Vallerie Lynn Gordon, Shantanu Otto Banerji · 2013 · Clinical Cancer Research
46. Mechanisms of DNA damage repair in adult stem cells and implications for cancer formation
    Clare E. Weeden, Marie-Liesse Asselin-Labat · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
47. BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells
    Huai-Chin Chiang, Xiaowen Zhang, Jingwei Li, Xiayan Zhao, Jerry Chen, Howard T-H Wang, Ismail Jatoi, Andrew Jacob Brenner, Yanfen Hu, Rong Li · 2019 · Nucleic Acids Research
48. Normal morphogenesis of epithelial tissues and progression of epithelial tumors
    Chun‐Chao Wang, Leen Jamal, Kevin A. Janes · 2011 · WIREs Systems Biology and Medicine
49. The Mammary Stem Cell Hierarchy
    Nai Yang Fu, Geoffrey John Lindeman, Jane E. Visvader · 2014 · Current topics in developmental biology/Current Topics in Developmental Biology
50. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes
    Michael L. Gatza, Hsiu‐Ni Kung, Kimberly Blackwell, Mark W. Dewhirst, Jeffrey R. Marks, Jen‐Tsan Chi · 2011 · Breast Cancer Research
51. Deciphering the roles of lncRNAs in breast development and disease
    John Lalith Charles Richard, Pieter J.A. Eichhorn · 2018 · Oncotarget
52. BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
    Lukas Semmler, Cara Reiter–Brennan, Andreas Klein · 2019 · Journal of Breast Cancer
53. High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia
    Pelissier Vatter, Fanny A., Schapiro, Denis, Chang, Hang, Borowsky, Alexander D., Lee, Jonathan K., Parvin, Bahram, Stampfer, Martha R., LaBarge, Mark A., Bodenmiller, Bernd, Lorens, James B. · 2018 · Cell Reports
54. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis
    Felipe Correa Geyer, Magali Lacroix‐Triki, Pierre‐Emmanuel Colombo, Neill Patani, Arnaud Gauthier, Rachael Natrajan, Maryou B.K. Lambros, Ibrahim Moustafa Khalifeh, Constance T. Albarracin, Sandra Orru et al. · 2012 · Histopathology
55. Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
    Giusy Tornillo, Catherine N. Knowlson, Howard D. Kendrick, Joe Cooke, Hasan Mirza, Iskander Aurrekoetxea-Rodríguez, María dM Vivanco, Niamh E. Buckley, Anita E. Grigoriadis, Matthew John Smalley · 2018 · Cell Reports
56. Single Cell RNA Sequencing of Human Milk-Derived Cells Reveals Sub-Populations of Mammary Epithelial Cells with Molecular Signatures of Progenitor and Mature States: a Novel, Non-invasive Framework for Investigating Human Lactation Physiology
    Jayne F. Martin Carli, George Devon Trahan, Kenneth L. Jones, Nicole M. Hirsch, Kristy P. Rolloff, EMILY Z. DUNN, Jacob E. Friedman, Linda A. Barbour, Teri L. Hernandez, Paul S. MacLean et al. · 2020 · Journal of Mammary Gland Biology and Neoplasia
57. Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels
    Zijian Zhu, Lai Jiang, Xianting Ding · 2023 · Cancers
58. Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures
    Khoa A. Tran, V. Addala, R. L. Johnston, David Lovell, Andrew Bradley, L. Koufariotis, S. Wood, Sunny Z. Wu, D. Roden, Ghamdan Al-Eryani et al. · 2023 · Nature Communications
59. Developmental Changes in the in Vitro Activated Regenerative Activity of Primitive Mammary Epithelial Cells
    Maisam Makarem, Nagarajan Kannan, Long V. Nguyen, David J. H. F. Knapp, Sneha Balani, Michael D. Prater, Julia Stingl, Afshin Raouf, Oksana Nemirovsky, Peter D. Eirew et al. · 2013 · PLoS Biology
60. Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics
    Ming Luo, Xiaofeng Zhao, Song Chen, Suling Liu, Max S. Wicha, Jun‐Lin Guan · 2013 · Cancer Research
61. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
    Priyanka Sharma, Shane Richard Stecklein, Bruce F. Kimler, Geetika Sethi, Brian K. Petroff, Teresa A. Phillips, Ossama William Tawfik, Andrew K. Godwin, Roy A. Jensen · 2014 · journal of cancer therapeutics and research
62. microRNAs and EMT in Mammary Cells and Breast Cancer
    Josephine A. Wright, Jennifer K. Richer, Gregory J. Goodall · 2010 · Journal of Mammary Gland Biology and Neoplasia
63. Heterogeneity of breast cancer: etiology and clinical relevance
    Vanessa Almendro, Gemma Fuster · 2011 · Clinical & Translational Oncology
64. The Luminal Progenitor Compartment of the Normal Human Mammary Gland Constitutes a Unique Site of Telomere Dysfunction
    Nagarajan Kannan, Nazmul Huda, LiRen Tu, Radina Droumeva, Geraldine Aubert, Elizabeth A. Chavez, Ryan R. Brinkman, Peter M. Lansdorp, Joanne T. Emerman, Satoshi Abe et al. · 2013 · Stem Cell Reports
65. A cancer stem cell origin for human endometrial carcinoma?
    Sonya A. Hubbard, Caroline E. Gargett · 2010 · Reproduction
66. Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer
    Davide Pellacani, Susanna Tan, Sylvain Lefort, Connie J. Eaves · 2019 · The EMBO Journal
67. CCAAT/Enhancer Binding Protein Beta Regulates Stem Cell Activity and Specifies Luminal Cell Fate in the Mammary Gland
    Heather L. LaMarca, Adriana P. Visbal, Chad J. Creighton, Hao Liu, Yiqun Zhang, Fariba Behbod, Jeffrey M. Rosen · 2010 · Stem Cells
68. Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis
    Joshua Chuck Harrell, Adam D. Pfefferle, Nicole Zalles, Aleix Prat, Cheng Fan, Andrey Khramtsov, Olufunmilayo Ibironke Olopade, Melissa A. Troester, Andrew C. Dudley, Charles M. Perou · 2013 · Clinical & Experimental Metastasis
69. Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
    Ellen R. Langille, Khalid N. Al‐Zahrani, Zhibo Ma, Minggao Liang, Liis Uusküla-Reimand, Roderic Espín, Katie Teng, Ahmad Malik, Helga Bergholtz, Samah El Ghamrasni et al. · 2022 · Cancer Discovery
70. Regulation of self‐renewal in normal and cancer stem cells
    Maria Vittoria Verga Falzacappa, Chiara Ronchini, Linsey B. Reavie, Pier Giuseppe Pelicci · 2012 · FEBS Journal
71. Progesterone regulation of stem and progenitor cells in normal and malignant breast
    Sunshine Daddario Axlund, Carol A. Sartorius · 2011 · Molecular and Cellular Endocrinology
72. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency
    Melanie Werner‐Klein, Ana Grujovic, Christoph Irlbeck, Milan M. S. Obradović, Martin Hoffmann, Huiqin Koerkel-Qu, Xin Lu, Steffi Treitschke, Cäcilia Köstler, Catherine Botteron et al. · 2020 · Nature Communications
73. Through a Glass Darkly: Advances in Understanding Breast Cancer Biology, 2000–2010
    LA Carey · 2010 · Clinical Breast Cancer
74. The tumor-nerve circuit in breast cancer
    Qiuxia Cui, Dewei Jiang, Yuanqi Zhang, Ceshi Chen · 2023 · Cancer and Metastasis Reviews
75. The two faces of Janus kinases and their respective STATs in mammary gland development and cancer
    Kay‐Uwe Wagner, Jeffrey W. Schmidt · 2011 · Journal of Carcinogenesis
76. Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity
    Aleix Prat, Bárbara Adamo, Cheng Fan, Vicente Peg, Maria Jesus Vidal, Patricia Galván, Ana P. Vivancos, Paolo Giovanni Nuciforo, Héctor G. Pálmer, Shaheenah S. Dawood et al. · 2013 · Scientific Reports
77. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis
    Mejdi Moumen, Aurélie Chiche, Charles Decraene, Valérie Petit, Alberto Gandarillas, Marie‐Ange Deugnier, Marina A. Glukhova, Marisa M. Faraldo · 2013 · Molecular Cancer
78. Human Milk Protein Production in Xenografts of Genetically Engineered Bovine Mammary Epithelial Stem Cells
    Eugenio Martignani, Peter D. Eirew, Paolo Accornero, Connie J. Eaves, Mario Baratta · 2010 · PLoS ONE
79. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
    Lina Ding, Ying Su, Anne Fassl, Kunihiko Hinohara, Xintao Qiu, Nicholas W. Harper, Sung Jin Huh, Noga Bloushtain-Qimron, Bojana Jovanović, Muhammad B. Ekram et al. · 2019 · Nature Communications
80. Multipotent luminal mammary cancer stem cells model tumor heterogeneity
    Lei Bao, Robert D. Cardiff, Paul A. Steinbach, Karen S. Messer, Lesley G. Ellies · 2015 · Breast Cancer Research
81. Regulation of stem cell function by protein ubiquitylation
    Alexandros Strikoudis, María Guillamot, Iannis Aifantis · 2014 · EMBO Reports
82. Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells
    Sara Lombardi, Gabriella Honeth, Christophe Ginestier, Ireneusz Shinomiya, Rebecca Marlow, Bharath Buchupalli, Patrycja Gazińska, John Brown, Steven Catchpole, Suling Liu et al. · 2014 · Stem Cell Reports
83. Mammary Development and Breast Cancer: The Role of Stem Cells
    C. Ercan, P. J. van Diest, Marc Vooijs · 2011 · Current Molecular Medicine
84. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
    Gabriel G. Malouf, Xiaoping Su, Jianping Zhang, Chad J. Creighton, Thai H. Ho, Yue Lu, Noël J.‐M. Raynal, Jose Antonio Karam, Pheroze Tamboli, Frederick Allanick et al. · 2016 · Clinical Cancer Research
85. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities
    Alison E. Casey, Ankit Sinha, Rajat Singhania, Julie M. Livingstone, Paul D. Waterhouse, Pirashaanthy Tharmapalan, Jennifer Cruickshank, Mona Shehata, Erik Drysdale, Hui Fang et al. · 2018 · The Journal of Cell Biology
86. Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome
    Weiyan Chen, Samuel Morabito, Kai Kessenbrock, Tariq Enver, Kerstin B. Meyer, Andrew Erich Teschendorff · 2019 · Communications Biology
87. Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?
    François Vaillant, Geoffrey John Lindeman, Jane E. Visvader · 2011 · Breast Cancer Research
88. Mammary gland stem cells and their application in breast cancer
    Xing Yang, Hui Wang, Baowei Jiao · 2016 · Oncotarget
89. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes
    So Yeon Park, Hyeong Ju Kwon, Yoomi Choi, Hee Eun Lee, Sung‐Won Kim, Jee Hyun Kim, In Ah Kim, Namhee Jung, Nam‐Yun Cho, Gyeong Hoon Kang · 2011 · Modern Pathology
90. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue)loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer
    Sze Yee Phuah, Lai‐Meng Looi, Norhashimah Hassan, Anthony Rhodes, Sarah Dean, Nur Aishah Mohd Taib, Cheng Har Yip, Soo‐Hwang Teo · 2012 · Breast Cancer Research
91. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers
    Xiaohong Rose Yang, Jonine D. Figueroa, Roni T. Falk, Hong Zhang, Ruth M. Pfeiffer, Stephen M. Hewitt, Jolanta Lissowska, Beata Pepłońska, Louise Annette Brinton, Montserrat García‐Closas et al. · 2012 · Breast Cancer Research
92. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers
    Niamh E. Buckley, C Nic An tSaoir, Jaine K. Blayney, L. C. Oram, Nyree Crawford, Zenobia D’Costa, J. E. Quinn, Richard D. Kennedy, Denis Paul Harkin, Paul B. Mullan · 2013 · Nucleic Acids Research
93. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis
    Josiah Ochieng, Gladys N. Nangami, Olugbemiga Ogunkua, Isabelle Racine Miousse, Igor Koturbash, Valerie Odero-Marah, Lisa J. McCawley, Pratima Nangia‐Makker, Nuzhat Ahmed, Yunus Luqmani et al. · 2015 · Carcinogenesis
94. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models
    M. Angeles Lillo, Cydney M. Nichols, Chanel D. Perry, Stephanie Runke, Raisa I. Krutilina, Tiffany Nicole Seagroves, Gustavo A. Miranda‐Carboni, Susan A. Krum · 2016 · Journal of Applied Toxicology
95. Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers
    Daisong Wang, Xin Hu, Chunye Liu, Yingying Jia, Yiqin Bai, Cheguo Cai, Jingqiang Wang, Lanyue Bai, Ruikai Yang, Changdong Lin et al. · 2019 · Cell Research
96. Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis
    Kohei Saeki, Gregory Chang, Noriko Kanaya, Xiwei Wu, Jinhui Wang, Lauren Bernal, Desiree Ha, Susan L. Neuhausen, Shiuan Chen · 2021 · Communications Biology
97. Deciphering functional tumor states at single‐cell resolution
    Rolando Vegliante, Ievgenia Pastushenko, Cédric Blanpain · 2021 · The EMBO Journal
98. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium
    Gabriella Honeth, Sara Lombardi, Christophe Ginestier, Min-Hee Hur, Rebecca Marlow, Bharath Buchupalli, Ireneusz Shinomiya, Patrycja Gazińska, Silvia Bombelli, Vernie Ramalingam et al. · 2014 · Breast Cancer Research
99. The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
    François Bertucci, Pascal Finetti, Anthony Gonçalvès, Daniel Birnbaum · 2020 · npj Breast Cancer
100. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal
     Aurélie Chiche, Mejdi Moumen, Valérie Petit, Jos Jonkers, Daniel Medina, Marie‐Ange Deugnier, Marisa M. Faraldo, Marina A. Glukhova · 2013 · Stem Cells